Rein Therapeutics Inc.

NASDAQ: RNTX · Real-Time Price · USD
1.16
0.00 (0.43%)
At close: Aug 15, 2025, 2:46 PM

Rein Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-62.88M -15.73M -27.33M -26.16M
Depreciation & Amortization
63K 119K 169K 121K
Stock-Based Compensation
1.12M 1.19M 2.08M 2.26M
Other Working Capital
2.69M -399K -90K 628K
Other Non-Cash Items
37M -4K -208K -213K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.41M -5.38M 420K 242K
Operating Cash Flow
-22.29M -19.81M -24.86M -23.75M
Capital Expenditures
n/a n/a n/a -157K
Cash Acquisitions
n/a -96K n/a n/a
Purchase of Investments
n/a n/a -21.85M -73.58M
Sales Maturities Of Investments
n/a 16.25M 48.31M 37.75M
Other Investing Acitivies
n/a 42K n/a 66K
Investing Cash Flow
n/a 16.2M 26.46M -35.92M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7.17M 15.79M n/a 74K
Financial Cash Flow
17.82M 15.79M n/a 55.66M
Net Cash Flow
-4.47M 12.12M 1.59M -4.01M
Free Cash Flow
-22.29M -19.81M -24.86M -23.91M